AVANOS MEDICAL, INC. AVNS Income Statement

Avanos medical, inc. (AVNS)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Sep'13
Net Sales
713,800	697,600	677,700	671,400	660,100	652,300	648,700	634,100	622,300	611,600	-170,800	76,200	327,100	566,200	518,300	510,300	499,600	509,000	1,612,400	1,631,400	1,655,600	1,672,100	1,652,200	0	0	0
Cost of products sold
308,300	295,400	284,800	268,800	261,500	261,400	268,300	277,400	275,800	274,700	-299,800	-109,800	84,900	269,000	243,300	242,300	237,400	251,200	1,057,900	1,075,700	1,129,900	1,123,500	1,098,600	0	0	0
Gross Profit
405,500	402,200	392,900	402,600	398,600	390,900	380,400	356,700	346,500	336,900	129,000	186,000	242,200	297,200	275,000	268,000	262,200	257,800	554,500	555,700	525,700	548,600	553,600	0	0	0
Research and development
36,900	37,700	39,900	40,800	42,100	41,800	43,300	42,400	40,800	38,200	35,400	36,700	37,000	38,400	34,200	33,500	30,300	27,600	30,000	28,300	31,300	33,600	35,000	0	0	0
Selling and general expenses
383,800	399,100	383,400	375,300	360,400	340,400	329,900	322,000	323,300	321,700	289,500	311,400	338,200	346,200	350,500	347,400	345,300	349,700	426,600	440,700	436,200	424,500	380,600	0	0	0
Goodwill impairment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-
Other expense, net
-15,300	-21,100	-30,400	-22,200	-13,200	-8,200	-1,400	-3,900	-14,900	-20,100	-22,900	-25,400	-24,800	-19,700	-31,700	-35,100	-30,100	-16,200	3,400	13,400	15,300	3,800	2,600	0	0	0
Operating Income (Loss)
-30,500	-55,700	-60,800	-35,700	-17,100	500	5,800	-11,600	-32,500	-43,100	-218,800	-187,500	-157,800	-107,100	334,100	-148,000	-143,500	-135,700	-374,200	100,100	73,500	94,300	140,600	0	0	0
Interest income
5,000	6,700	8,100	9,000	9,200	7,800	6,300	4,800	3,100	2,500	1,700	1,200	800	600	600	400	400	300	200	1,200	2,000	2,900	3,600	0	0	0
Interest expense
15,600	15,000	14,200	14,900	21,300	26,400	31,000	34,900	32,800	31,600	31,500	31,800	32,300	32,700	32,800	32,200	32,800	33,100	30,900	23,200	14,300	6,000	100	0	0	0
Loss Before Income Taxes
-41,100	-64,000	-66,900	-41,600	-29,200	-18,100	-18,900	-41,700	-62,200	-72,200	-248,600	-218,100	-189,300	-139,200	301,900	-179,800	-175,900	-168,500	-404,900	78,100	61,200	91,200	144,100	0	0	0
Income tax benefit
-19,200	-18,100	-24,400	-14,800	-11,700	-9,600	-17,500	-25,900	-33,700	-40,100	-99,000	-87,800	-76,900	-55,900	-67,500	-69,600	-67,200	-67,300	38,300	58,200	53,800	64,100	66,700	0	0	0
Loss from Continuing Operations
-	-	-42,500	-26,800	-	-8,500	-1,400	-15,800	-28,500	-32,100	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Income from discontinued operations, net of tax
-	-	500	500	-	66,000	93,900	120,700	115,200	111,400	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income (Loss)
-21,900	-45,900	-42,000	-26,300	17,000	57,500	92,500	104,900	86,700	79,300	56,500	49,000	38,400	39,800	44,300	-435,300	-433,800	-426,300	-443,200	19,900	7,400	27,100	77,400	0	0	0
Earnings (Loss) Per Share
Basic:
Continuing operations (in dollars per share)
-	-	-0.24	-0.17	-	-0.06	0.09	0.03	-0.24	0.09	-0.22	-0.24	-0.32	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued operations (in dollars per share)
-	-	0.00	0.00	-	0.01	0.00	0.72	0.67	0.61	0.57	0.61	0.59	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic (in dollars per share)
0.08	-0.12	-0.24	-0.17	-0.43	-0.05	0.09	0.75	0.43	0.70	0.35	0.37	0.27	0.22	0.19	0.14	0.30	0.31	-10.10	0.17	0.47	-0.05	-0.16	-0.10	0.89	-
Diluted:
Continuing operations (in dollars per share)
-	-	-0.24	-0.17	-	-0.06	0.09	0.03	-0.24	0.09	-0.22	-0.24	-0.32	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued operations (in dollars per share)
-	-	0.00	0.00	-	0.03	0.00	0.70	0.67	0.61	0.57	0.61	0.59	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (in earnings per share)
0.08	-0.12	-0.24	-0.17	-0.43	-0.03	0.09	0.73	0.43	0.70	0.35	0.37	0.27	0.22	0.19	0.14	0.30	0.32	-10.10	0.17	0.46	-0.05	-0.16	-0.10	0.89	-